Endoscopic Submucosal Dissection in the Treatment of Patients With Papillary Early Gastric Cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: papillary early gastric cancer remains controversial
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Although the use of endoscopic submucosal dissection in the treatment of early gastric cancer is gradually expanding, its application in patients with papillary early gastric cancer remains controversial. This study helps to identify appropriate indications for endoscopic submucosal dissection in patients with papillary early gastric cancer.
Papillary adenocarcinoma is a histological type of gastric adenocarcinoma with a very low incidence; therefore, little research has been conducted into this tumor type and no clear treatment guideline
APA
Kim JS (2025). Endoscopic Submucosal Dissection in the Treatment of Patients With Papillary Early Gastric Cancer.. The Korean journal of helicobacter and upper gastrointestinal research, 25(1), 78-80. https://doi.org/10.7704/kjhugr.2024.0065
MLA
Kim JS. "Endoscopic Submucosal Dissection in the Treatment of Patients With Papillary Early Gastric Cancer.." The Korean journal of helicobacter and upper gastrointestinal research, vol. 25, no. 1, 2025, pp. 78-80.
PMID
40550533 ↗
Abstract 한글 요약
Papillary adenocarcinoma is a histological type of gastric adenocarcinoma with a very low incidence; therefore, little research has been conducted into this tumor type and no clear treatment guidelines have been developed. Papillary adenocarcinoma is classified as a differentiated-type gastric cancer, according to the Japanese guidelines, but is known to have a high risk of lymph node metastasis. Although the use of endoscopic submucosal dissection in the treatment of early gastric cancer is gradually expanding, its application in patients with papillary early gastric cancer remains controversial. This study helps to identify appropriate indications for endoscopic submucosal dissection in patients with papillary early gastric cancer.
같은 제1저자의 인용 많은 논문 (5)
- Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.
- Radiomics-Based Prediction of Lymphedema after Radiotherapy in Breast Cancer: Integrating Clinical and Dosimetric Features.
- Response: Reassessing the Use of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC.
- Ultrasound-Based Classification of Infraorbital Fat and Groove Patterns: Clinical Implications for Safer Filler Injection.
- Attention-deficit/hyperactivity disorder in pediatric cancer survivors: risk and medication use in a nationwide population-based study.